NCT04504331 2026-02-12
Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer
Stanford University
Phase 1 Terminated
Clinical Trials
12 trialsNCT02297672 2026-02-02
PBSI
British Columbia Cancer Agency
Phase NA Active not recruiting
NCT03697577 2026-01-23
CDK and Body Composition Study
Montefiore Medical Center
Recruiting
NCT05035407 2025-12-02
T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers
National Institutes of Health Clinical Center (CC)
Phase 1 Terminated
NCT05775822 2024-02-07
RadioTherapy
Centro Cardiologico Monzino
Phase NA Completed
NCT05814224 2023-04-14
MAGNETIC1
Centro di Riferimento Oncologico - Aviano
Phase NA Unknown
NCT00584233 2022-12-06
Evaluation of Breast CT
University of California, Davis
Phase NA Completed
NCT02706964 2022-06-30
BCMetPats
University of Florida
Phase NA Completed
NCT02708511 2018-04-05
Copper Cu 64-DOTA-B-Fab PET/CT in Imaging Patients With Ovarian and Breast Cancer
Stanford University
Phase 1 Terminated
NCT03266744 2017-08-30
RESPECT
East and North Hertfordshire NHS Trust
Phase NA Unknown
NCT01090687 2013-08-01
Role of 3D Tomography in Breast Cancer
University of Rochester
Completed
NCT01107860 2013-06-18
Cone Beam Computed Tomography for Breast Imaging
Koning Corporation
Completed